Other languages Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
3.06 ^USD	-0.33%		-1.29%	-4.97%

Apr. 30	B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	MT
Apr. 29	HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 08
Ovid Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03
Ligand Acquires 13% Stake in Ovid Therapeutics' Soticlestat Royalties for $30 Million	23-10-18
Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04
Ovid Therapeutics Inc. Announces Changes to Its Board	23-06-28
Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05
Ovid Therapeutics Inc. Enters into an Exclusive Collaboration and License Agreement with Graviton Bioscience Corporation	23-05-01
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-13
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-13
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-13
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-13
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments	23-02-08
Ovid Therapeutics Doses Healthy Volunteers with OV329 in Phase 1 Trial	23-01-05
Ovid Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08
Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09
ANALYSE/"Long Covid" ist für große Pharmakonzerne schwer zu packen	22-07-11
Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $1.4M	22-05-10
Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Other languages

Filters